Article thumbnail
Location of Repository

In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR)

By Yosef Landesman, Nenad Svrzikapa, Armand Cognetta, Xuemei Zhang, Brian R Bettencourt, Satya Kuchimanchi, Keri Dufault, Sarfraz Shaikh, Maple Gioia, Akin Akinc, Renta Hutabarat and Rachel Meyers
Topics: Methodology
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2939650
Provided by: PubMed Central

Suggested articles

Citations

  1. (2003). AA: Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2′-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species. Drug Metab Dispos
  2. (1990). and characterization of liver cell types. Methods Enzymol
  3. (2008). AR: Delivery vehicles for small interfering RNA in vivo. Hum Gene Ther
  4. (2008). de Fougerolles A: Delivering silence: advancements in developing siRNA therapeutics. Curr Opin Drug Discov Devel
  5. (2009). DG: Development of lipidoidsiRNA formulations for systemic delivery to the liver. Mol Ther
  6. (2010). DG: Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci USA
  7. (2008). Examination of real-time polymerase chain reaction methods for the detection and quantification of modified siRNA. Anal Biochem
  8. (2005). Guegler KJ: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res
  9. (2006). I: RNAi-mediated gene silencing in non-human primates. Nature
  10. (2007). Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov
  11. (2010). Linsley PS: Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application. Nat Rev Drug Discov
  12. (2010). MJ: Rational design of cationic lipids for siRNA delivery. Nat Biotechnol
  13. (2009). Oldfield PR: Bioanalysis of siRNA and oligonucleotide therapeutics in biological fluids and tissues. Bioanalysis
  14. (2005). Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs. Nat Biotechnol
  15. (2009). Stem-loop RT-PCR quantification of siRNAs in vitro and in vivo. Oligonucleotides

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.